Yüklüyor......
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial
AIMS : Mortality rates from chronic kidney disease (CKD) have increased in the last decade. In this pre-specified analysis of the DAPA-CKD trial, we determined the effects of dapagliflozin on cardiovascular and non-cardiovascular causes of death. METHODS AND RESULTS : DAPA-CKD was an international,...
Kaydedildi:
| Yayımlandı: | Eur Heart J |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8244648/ https://ncbi.nlm.nih.gov/pubmed/33792669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehab094 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|